Literature DB >> 22730538

Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia.

Kazunobu Kiyomizu1, Hirokazu Kashiwagi, Tsuyoshi Nakazawa, Seiji Tadokoro, Shigenori Honda, Yuzuru Kanakura, Yoshiaki Tomiyama.   

Abstract

Platelet-associated (PA) IgG autoantibodies play an essential role in primary immune thrombocytopenia (ITP). However, little is known about the epitopes of these Abs. This study aimed to identify critical binding regions for PA anti-αIIbβ3 Abs. Because PA anti-αIIbβ3 Abs bound poorly to mouse αIIbβ3, we created human-mouse chimera constructs. We first examined 76 platelet eluates obtained from patients with primary ITP. Of these, 26 harbored PA anti-αIIbβ3 Abs (34%). Further analysis of 15 patients who provided sufficient materials showed that the epitopes of these Abs were mainly localized in the N-terminal half of the β-propeller domain in αIIb (L1-W235). We could identify 3 main recognition sites in the region; 2 eluates recognized a conformation formed by the W1:1-2 and W2:3-4 loops, 5 recognized W1:2-3, and 4 recognized W3:4-1. The remaining 4 eluates could not be defined by the binding sites. Within these regions, we identified residues critical for binding, including S29 and R32 in W1:1-2; G44 and P45 in W1:2-3; and P135, E136, and R139 in W2:3-4. Of 11 eluates whose recognition sites were identified, 5 clearly showed restricted κ/λ-chain usage. These results suggested that PA anti-αIIbβ3 Abs in primary ITP tended to recognize highly restricted regions of αIIb with clonality.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730538     DOI: 10.1182/blood-2012-02-409995

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Serum Copper and Zinc Levels in Primary Immune Thrombocytopenia.

Authors:  Gülden Sincan; Fuat Erdem; İlker Bay; Suat Sincan
Journal:  Biol Trace Elem Res       Date:  2022-05-30       Impact factor: 4.081

2.  Secondary immune thrombocytopenic purpura with renal cell carcinoma.

Authors:  Shigeaki Nakazawa; Masataka Kawamura; Kosuke Nakano; Norichika Ueda; Hidefumi Kishikawa; Hirokazu Kashiwagi; Motohide Uemura; Ryoichi Imamura; Kenji Nishimura; Norio Nonomura
Journal:  IJU Case Rep       Date:  2019-08-02

Review 3.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

Review 4.  Pathophysiology and management of primary immune thrombocytopenia.

Authors:  Hirokazu Kashiwagi; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2013-05-24       Impact factor: 2.490

5.  Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.

Authors:  Hirokazu Kashiwagi; Shinji Kunishima; Kazunobu Kiyomizu; Yoshiro Amano; Hiroyuki Shimada; Masashi Morishita; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Mol Genet Genomic Med       Date:  2013-04-22       Impact factor: 2.183

Review 6.  Emerging Concepts in Immune Thrombocytopenia.

Authors:  Maurice Swinkels; Maaike Rijkers; Jan Voorberg; Gestur Vidarsson; Frank W G Leebeek; A J Gerard Jansen
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.